Abstract
Microemulsions are clear, transparent, thermodynamically stable dispersions of oil and water, stabilised by an interfacial film of surfactant frequently in combination with a co-surfactant. Recently, there has been a considerable interest for the microemulsion formulation, for the delivery of hydrophilic as well as lipophilic drug as drug carriers because of its improved drug solubilisation capacity, long shelf life, easy of preparation and improvement of bioavailability. In this present review, we discuss about the various advantages of microemulsion in pharmaceuticals, along with its composition variables, physicochemical characterisation etc. The potential use of microemulsion for therapeutic application is also discussed.
Keywords: Microemulsion, surfactants, formulation, characterisation, bioavailability, sustained release, parenteral, pharmaceutical use
Current Drug Delivery
Title: Microemulsions: A Potential Drug Delivery System
Volume: 3 Issue: 2
Author(s): P. K. Ghosh and R. S.R. Murthy
Affiliation:
Keywords: Microemulsion, surfactants, formulation, characterisation, bioavailability, sustained release, parenteral, pharmaceutical use
Abstract: Microemulsions are clear, transparent, thermodynamically stable dispersions of oil and water, stabilised by an interfacial film of surfactant frequently in combination with a co-surfactant. Recently, there has been a considerable interest for the microemulsion formulation, for the delivery of hydrophilic as well as lipophilic drug as drug carriers because of its improved drug solubilisation capacity, long shelf life, easy of preparation and improvement of bioavailability. In this present review, we discuss about the various advantages of microemulsion in pharmaceuticals, along with its composition variables, physicochemical characterisation etc. The potential use of microemulsion for therapeutic application is also discussed.
Export Options
About this article
Cite this article as:
Ghosh K. P. and Murthy S.R. R., Microemulsions: A Potential Drug Delivery System, Current Drug Delivery 2006; 3 (2) . https://dx.doi.org/10.2174/156720106776359168
DOI https://dx.doi.org/10.2174/156720106776359168 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Heme Oxygenase-1 as a Target for the Design of Gene and Pharmaceutical Therapies for Autoimmune Diseases
Current Gene Therapy Neonatal Germ Cell Tumors
Current Pediatric Reviews Biomarkers of Lung Tissue Remodeling in Pulmonary Diseases: Implications for Clinical Practice and Research
Current Respiratory Medicine Reviews Increased Pulmonary Heme Oxygenase-1 and δ-Aminolevulinate Synthase Expression in Monocrotaline-Induced Pulmonary Hypertension
Current Neurovascular Research Emerging Therapeutic Approaches Multi-Targeting Receptor Tyrosine Kinases and G Protein-Coupled Receptors in Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry The Therapeutic Potential of RNA Interference: Novel Approaches for Cancer Treatment
Current Pharmaceutical Biotechnology The Heart in Sepsis: From Basic Mechanisms to Clinical Management
Current Vascular Pharmacology Regulation of Iron Absorption in Hemoglobinopathies
Current Molecular Medicine TRPM8: From Cold to Cancer, Peppermint to Pain
Current Pharmaceutical Biotechnology Tissue Doppler Imaging: Beautiful Noise
Current Cardiology Reviews Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature Review
Current Cardiology Reviews Amiodarone Hepatotoxicity
Current Vascular Pharmacology Editorial [Hot topic: TGF-β Signaling and its Inhibition: Implication in Fibrosis (Guest Editor: Asish K. Ghosh)]
Current Enzyme Inhibition The Use of N-Acetylcysteine in Respiratory Diseases
Current Respiratory Medicine Reviews Targeted Therapies and other Agents as First-Line Maintenance and Beyond: Particular Benefit in Pulmonary Adenocarcinoma Patients
Current Medicinal Chemistry Current Therapy in Sarcoidosis, the Role of Existing Drugs and Future Medicine
Inflammation & Allergy - Drug Targets (Discontinued) Torasemide in Hypertension and Heart Failure: Re-inventing Loop Diuretic Therapy?
Current Pharmaceutical Design Established Treatments of Psoriasis
Current Drug Targets - Inflammation & Allergy Pulmonary Complications After Congenital Heart Surgery
Current Respiratory Medicine Reviews Mast Cell Chymase and Tryptase as Targets for Cardiovascular and Metabolic Diseases
Current Pharmaceutical Design